Emerson Electric (EMR) Barclays 43rd Annual Industrial Select Conference summary
Event summary combining transcript, slides, and related documents.
Barclays 43rd Annual Industrial Select Conference summary
17 Feb, 2026Order and revenue trends
Trailing three-month orders grew 9%, with 12-month orders up 6% and backlog rising 9% in the quarter.
Growth was led by power generation, LNG, semiconductors, life sciences, and aerospace/defense, with strength in the U.S., Arabian Peninsula, Brazil, Japan, and Southeast Asia.
MRO order rates are in the mid-single-digit range, supporting ongoing business.
Test & Measurement markets are rebounding as expected, contributing to strong vertical performance.
No recovery is expected in China or Europe, and forecasts do not rely on improvement in these regions.
Market and industry dynamics
U.S. industrial economy is robust, with significant modernization and data center work in power generation.
Semiconductor and aerospace/defense markets are expanding, with innovation and customer-driven design as key differentiators.
Automotive and bulk chemicals remain weak globally, with overcapacity in chemicals expected to persist for 6-12 months.
Industrial policy in the U.S. aligns well with prioritized growth verticals.
Capital project funnel remains active, with strong backfilling of lost projects.
Innovation and technology strategy
Leading position in Test & Measurement for aerospace/defense, with customer-driven innovation and LabVIEW/Nigel software tools.
Semiconductor opportunities extend beyond T&M to valves, instruments, and control systems in fabs.
AI is being embedded in software products, with three new AI-enabled offerings and over $100 million in Ovation Virtual Advisor quotations.
Software business is protected by vertical specialization, mission-critical applications, and usage-based pricing models.
Customers are demanding AI within existing products, leveraging deep domain expertise.
Latest events from Emerson Electric
- AI-driven software growth and robust U.S. demand fuel strong performance and future outlook.EMR
Citi's Global Industrial Tech & Mobility Conference 202618 Feb 2026 - Q1 2026 saw 4% sales growth, 6% EPS growth, and raised guidance, driven by automation demand.EMR
Q1 20264 Feb 2026 - Targeting $21B sales, 30% EBITA margin, $8.00 EPS, and $10B shareholder returns by 2028.EMR
Investor Update3 Feb 2026 - Director elections and key proposals passed; board declassification did not meet approval threshold.EMR
AGM 20263 Feb 2026 - Q3 sales and adjusted EPS up 11%, Copeland exit boosts debt reduction and guidance raised.EMR
Q3 20242 Feb 2026 - Record FY24 growth, portfolio actions, and $2B buyback set up strong 2025 outlook.EMR
Q4 202416 Jan 2026 - Record margins, 13% EPS growth, and robust cash flow with AspenTech deal pending.EMR
Q1 20259 Jan 2026 - Strong financials, board declassification vote, and ESG progress highlight this year's proxy.EMR
Proxy Filing12 Dec 2025 - Key votes include board declassification, director elections, and executive pay approval.EMR
Proxy Filing12 Dec 2025